Eubiotics Market

According to Stratistics MRC, the Global Eubiotics Market is accounted for $5.09 billion in 2022 and is expected to reach $9.37 billion by 2028 growing at a CAGR of 10.7% during the forecast period. Eubiotics are manufactured and distributed by feed mills, pre-mixers, or particular distributors. Eubiotics are produced by businesses that either offers their goods directly to consumers or to integrate feed producers. In any case, the animal farmers receive the Eubiotics products. Eubiotics are produced using techniques like fermentation and chemical synthesis to create organic acids.

According to the World Bank, the adoption of industrialized meat production is growing 6 times faster than that of traditional meat production. According to WHO, about 2 million people in the U.S. suffer from antibiotic resistant infections each year while death toll reaches nearly 23,000.



Market Dynamics:

Driver:

Increasing prevalence of livestock diseases

One of the main elements fostering a favourable view for the market is the rising occurrence of livestock diseases around the world. Animals fed on feed based on eubiotics receive critical nutrients as well as health and therapeutic advantages, such as the early detection and treatment of chronic disorders. Also, rising consumer awareness of feed quality and safety is contributing to market expansion. In animals and livestock, eubiotics are frequently employed as an alternative to antibiotic growth promoters (AGPs). In accordance with this, the rising demand for Eubiotics is also being fuelled by the rising need for animal protein and meat. Additional causes, particularly in industrialised nations, are projected to push the domestication of animals as pets and the quick modernization of the cattle business.

Restraint:

Unawareness about eubiotics

Although being outlawed in some countries, antibiotics are nonetheless utilised in the livestock industry. Moreover, overusing antibiotics can encourage the development of antimicrobial resistance (AMR). Animals that develop antimicrobial resistance (AMR) do not respond to treatment, making illnesses harder to treat and raising the risk of disease transmission, serious illness, and death. Unfortunately, many farmers are reluctant to transition to eubiotics because they are unaware of the harmful effects of antibiotics. Therefore, a major commercial danger is the lack of knowledge about the advantages of eubiotics.

Opportunity:

New alternative approach of eubiotics

Recent scientific discoveries suggest that symbiotic (probiotics + prebiotics) can promote a healthy and increased rate of animal production in poultry diets. Aromatic compounds derived from plant polyphenols that have antioxidant capabilities and suppress bacterial extracellular enzymes and oxidative phosphorylation aid in preventing infections from utilising their metabolic substrates and absorbing nutrients. The body's immunological responses are improved by this function. Eubiotics are being adopted more widely across the globe as a result of growing understanding of the significance of healthy animal feed additives.

Threat:

Rising raw material prices

Increasing raw material costs are a significant issue for feed producers all over the world. Eubiotics come from organic materials like seeds, bark, and leaves. The market for eubiotics is being constrained by increasing extraction costs from these sources as well as strict rules on bio-waste materials and wastewater treatment. The animal feed industry is under a lot of pressure to find raw feeds like corn, wheat, and barley as the world's population rises and the resulting demand for food rises. Also, the cost of raw ingredients like plant extracts and essential oils is rising as a result of their new uses in pharmaceutical and cosmetic products. As a result, the operating expenses incurred by producers of feed additives are also rising. These elements will restrict market expansion during the anticipated term.

Covid-19 Impact

The eubiotics industry has been slightly impacted by the COVID-19 epidemic. Although firms have suffered financial losses as a result of significant mobility restrictions in significant markets, the industry's overall impact is mixed. The pandemic has, however, increased public awareness of the harmful effects of antibiotics in food animals, which has positively impacted the growth of the Eubiotics business. Worldwide closures of factories, production and manufacturing facilities, eateries, lodging facilities, and other businesses were brought on by COVID-19. This led to a lack of labour, a breakdown in the supply chain, and a decrease in the supply of raw materials and other supplies.

The organic acids segment is expected to be the largest during the forecast period

The organic acids segment is estimated to have a lucrative growth. These acids are employed in animal nutrition as forage and grain preservatives. They help to improve the utilisation of feed resources by preventing the formation of mould and bacterial infections. They can be applied to projects including poultry, aquaculture, and pigs. The use of organic acids has shown to be a successful remedy for problems with feed quality and sanitation. Over the course of the projection period, all these characteristics are anticipated to fuel segment growth for organic acids.

The gut health segment is expected to have the highest CAGR during the forecast period

The gut health segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the fact that animals frequently experience problems with their digestive systems as well as the rising popularity of preventative healthcare. Eubiotics products aid in aggregating the microbiota production in the animal's digestive tract, improving digestion and the immune system. Gut integrity can be improved by using products like probiotics, probiotics, organic acids, and essential oils, among others. To get better results, these products can be used separately or in combination.

Region with highest share:

North America is projected to hold the largest market shares during the forecast period owing to eubiotics are being used more and more in the livestock field industry. Also, the existence of multiple eubiotics manufacturing enterprises in this area is anticipated to foster the market's expansion there. Due to the rising demand for products made from animals and the expansion of government regulation to safeguard the animal husbandry industry, Europe is now following North America. Also, farmers in this area are employing eubiotics to raise their livestock and meet demand because they are more aware of the negative effects of alternatives to eubiotics.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to rising public knowledge of the advantages of eubiotics, the implementation of strict restrictions, and a ban on the use of antibiotics. The adoption of high-quality feed additives in this region, together with growing concerns about animal health and safety, are driving the expansion of the eubiotics market. The market in Europe has been further bolstered by technical improvements, expenditures in research & development, and the presence of major companies.



Key players in the market

Some of the key players profiled in the Eubiotics Market include BEHN MEYER, DSM, Novus International, Inc., Advanced BioNutrition Corp, Lallemand, Inc., DuPont de Nemours, Inc., Associated British Foods plc, Novozymes, Calpis Co., Ltd., UAS Laboratories, BENEO, Koninklijke DSM N.V, Lesaffre Group, Evonik Industries AG, Chr. Hansen Holding A/S, Cargill, Incorporated, BASF SE, Biomin, ADM and Bluestar Adisseo Co.

Key Developments:

In July 2021, Koninklijke DSM N.V, a Netherlands-based multinational corporation that is engaged in the fields of materials, health, and nutrition, announced that they have acquired Midori USA, Inc., a biotechnological start-up company that is engaged in developing innovative targeted eubiotics that significantly enhance the environmental impact and health of the animals.

In January 2021, Novus International, Inc., a dominant player that provides nutrition and health solutions in the animal agriculture industry, announced that they have partnered with Agrivida, a Massachusetts-based biotech innovator, in order to expand their customer base as well as implore pristine and creative products and solutions with the help of R&D collaboration.

Products Covered:
• Prebiotics
• Probiotics
• Organic Acids
• Essential Oil
• Enzymes
• Phytogenic
• Other Products

Forms Covered:
• Liquid
• Solid

Livestock’s Covered:
• Poultry
• Swine
• Ruminants
• Aquatic Animals
• Other Livestock’s

Applications Covered:
• Immunity
• Gut Health
• Yield
• Nutrition
• Other Applications

End Users Covered:
• Poultry Feed
• Cattle Feed
• Swine Feed
• Aquatic Feed
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances